
SEMA-1
10 mg · 15 mg · 20 mg
View product →Product details are loading.

10 mg · 20 mg · 30 mg
Sign in with an eligible account to view pricing and availability.
Account access
RETA-3 is a peptide research compound associated with the research identifier LY3437943. Published research describes the reference molecule as a single peptide with activity at GLP-1, GIP and glucagon receptors. These details describe the reference molecule; the certificate reports analytical results for the material tested.
Explore the certificate
Identity, purity and peptide content each tell you something different.
Infrared light produces a chemical fingerprint that helps the laboratory assess the material’s identity.
Chromatography separates components into distinct peaks, helping the laboratory assess purity under the test conditions.
The content assay reports the amount of peptide measured. A high purity percentage alone does not tell you how many milligrams are present.
Results apply to the material tested.
View the analysisReports are listed by the amount and lot shown in each document. Results apply only to the tested sample and do not confirm the selected package or current inventory.
Measured content (112.7%) is above the report’s stated 90–110% potency specification.
View full certificatePurity is the chromatographic HPLC result, not the proportion of peptide in the total powder. The report records excipients but does not name them. Results refer only to the material tested as received; they do not confirm the selected variant or current inventory.
Reference identity. Certificate results are reported separately.
For laboratory research only. Not for human or animal use. Product and report details do not provide administration or treatment guidance.